BioCentury
ARTICLE | Company News

Actelion seeks FDA approval of macitentan for PAH

October 23, 2012 1:07 AM UTC

Actelion Ltd. (SIX:ATLN) submitted an NDA to FDA for Opsumit macitentan to treat pulmonary arterial hypertension. The application is based on data from the Phase III SERAPHIN trial, which showed Opsum...